These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10688731)

  • 21. [Cardiac toxicity and UFT].
    Marcos Sánchez F; Albo Castaño I; Arbol Linde F; Juárez Ucelay F; Durán Pérez-Navarro A
    An Med Interna; 2003 Jan; 20(1):50. PubMed ID: 12666313
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer.
    Ueno H; Okada S; Okusaka T; Ikeda M; Kuriyama H
    Oncology; 2002; 62(3):223-7. PubMed ID: 12065869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combination chemotherapy with tegafur-uracil (UFT) and cisplatin (CDDP) for advanced gastric cancer. UFTP Study Group].
    Sato A; Hasegawa K; Kurihara M; Takahashi M; Akazawa S; Fukuyama Y; Koizumi W; Hayakawa M; Sasai T; Kimura K
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1355-62. PubMed ID: 7668870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double blind comparative study of tegafur (FT) and UFT (a combination of Tegafur and uracil) in advanced breast cancer.
    Tashiro H; Nomura Y; Ohsaki A
    Jpn J Clin Oncol; 1994 Aug; 24(4):212-7. PubMed ID: 8072200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UFT modulated with leucovorin in advanced colorectal cancer: Oncopaz experience.
    González Barón M; Feliu J; Garcia Girón C; Espinosa J; Martinez B; Blanco E; Crespo MC; Ordóñez A; Espinosa E; de Castro J; Juárez F; Colmenarejo A
    Oncology; 1997; 54 Suppl 1():24-9. PubMed ID: 8978581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer.
    Hoff PM; Janjan N; Saad ED; Skibber J; Crane C; Lassere Y; Cleary KR; Benner S; Randolph J; Abbruzzese JL; Pazdur R
    J Clin Oncol; 2000 Oct; 18(20):3529-34. PubMed ID: 11032595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.
    Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Macrocytic anemia as a possible adverse effect of fluoropyrimidines].
    Arai K; Awane Y; Kitamura M; Miyashita K
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1489-94. PubMed ID: 2117887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics.
    Boku N; Ohtsu A; Muro K; Kaneko K; Muto M; Ohkuwa M; Ishii H; Sasaki Y; Tajiri H; Yoshida S; Kusada O
    Jpn J Clin Oncol; 1996 Oct; 26(5):379-83. PubMed ID: 8895681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of apoptosis in human tumour xenografts after oral administration of uracil and tegafur to nude mice bearing tumours.
    Oki E; Sakaguchi Y; Toh Y; Oda S; Maehara Y; Yamamoto N; Sugimachi K
    Br J Cancer; 1998 Sep; 78(5):625-30. PubMed ID: 9744503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer.
    Sanchiz F; Milla A
    Jpn J Clin Oncol; 1994 Dec; 24(6):322-6. PubMed ID: 7830337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose oral tegafur-uracil maintenance therapy in patients with uterine cervical cancer.
    Sakaguchi I; Motohara T; Saito F; Takaishi K; Fukumatsu Y; Tohya T; Shibata S; Mimori H; Tashiro H; Katabuchi H
    J Gynecol Oncol; 2015 Jul; 26(3):193-200. PubMed ID: 25686399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study).
    Nishina T; Moriwaki T; Shimada M; Higashijima J; Sakai Y; Masuishi T; Ozeki M; Amagai K; Negoro Y; Indo S; Denda T; Sato M; Yamamoto Y; Nakajima G; Mizuta M; Takahashi I; Hiroshima Y; Ishida H; Maeba T; Hyodo I
    Clin Colorectal Cancer; 2016 Sep; 15(3):236-42. PubMed ID: 26778644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.
    Pazdur R; Lassere Y; Rhodes V; Ajani JA; Sugarman SM; Patt YZ; Jones DV; Markowitz AB; Abbruzzese JL; Bready B
    J Clin Oncol; 1994 Nov; 12(11):2296-300. PubMed ID: 7964943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer.
    Sugimachi K; Maehara Y; Ogawa M; Kakegawa T; Tomita M
    Cancer Chemother Pharmacol; 1997; 40(3):233-8. PubMed ID: 9219507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
    Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
    J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of five studies on tegafur plus uracil (UFT) as post-operative adjuvant chemotherapy for breast cancer.
    Kasumi F; Yoshimoto M; Uchino J; Abe R; Nomura Y; Sugimachi K; Nakazato H; Abe O
    Oncology; 2003; 64(2):146-53. PubMed ID: 12566912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.
    Shibahara K; Yamamoto M; Kakeji Y; Sakata H; Maehara Y
    Anticancer Res; 2008; 28(3B):1779-83. PubMed ID: 18630459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UFT in gastric cancer: current status and future developments.
    Hanauske AR
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):113-8. PubMed ID: 9348582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.